Ritalin at 75: what does the future hold?
Seventy-five years ago, a new stimulant drug with the generic name of methylphenidate was born in the Swiss lab of chemical company Ciba. Like many drugs, its therapeutic purpose was unclear. But these were the days a scientist could take a drug home and test it on their spouse, which is exactly what Ciba scientist Leandro Panizzon did. Panizzon’s wife, Rita, reported that the drug gave her tennis game a real fillip. And so Panizzon named the drug Ritaline in his wife’s honour.
Other Articles in this Edition
Early maternal anemia tied to intellectual disability, ADHD and autism
Prenatal acetaminophen exposure tied to greater ADHD risk in offspring
Heat-Related Illness and ADHD Athletes
Convergence in neuropsychiatric research
11 Ways Plants Enhance Your Mental and Emotional Health
‘Let things unfold in their own time’: 7 parents share helpful tips on raising a child with ADHD
How supervisors can support employees with ADHD
Ritalin at 75: what does the future hold?
A Range of Pharmaceuticals for ADHD
Parental Jail Time May Sentence Kids to a Lifetime of Mental Illness